Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Liquid Biopsy and Its Significance on the Early Detection of Breast Cancer; [بیوپسی مایع و اهمیت آن در تشخیص زودهنگام سرطان پستان] Publisher



Hasannejad F1 ; Fazilat A1 ; Majidzadeh KA1
Authors

Source: Iranian Journal of Breast Diseases Published:2024


Abstract

Introduction: Liquid biopsy is a novel diagnostic tool that investigates biological biomarkers within the blood and other body liquids in order to provide information about the genetics of the tumor and its treatment response. The current review study aimed to highlight the role of liquid biopsy in breast cancer and precision medicine. Methods: In the current review study, we attempted to evaluate the recent innovations in breast cancer diagnosis by investigating liquid biopsy biomarkers in related databases, including Scopus, Web of Science, PubMed, and Google Scholar, from 2018 to 2024. Results: The assessment of the published articles in this field revealed that the applications of biomarkers in liquid biopsy have a significant role in personalized medicines, highlighting their reliability for use in personalized medicine. Conclusion: The liquid biopsy biomarkers seem to be a promising approach in breast cancer early detection and remarkable reduction of mortality caused by this disease in the near future. © 2024 Hasannejad et al.
Related Docs
View other Related Docs
1. A Review of Salivary Biomarkers in Breast Cancer, Current Women's Health Reviews (2023)
2. Liquid Biopsy in Urogenital Cancers and Its Clinical Utility, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
3. Salivary Biomarkers in Breast Cancer Diagnosis: A Systematic Review and Diagnostic Meta-Analysis, Cancer Medicine (2022)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Kazem Aghamir Mohammad Ali (6)
Maryam Koopaie (3)
Other Related Docs
4. Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors, Epigenetics Insights (2020)
5. Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer, Molecular Therapy Nucleic Acids (2018)
6. Circulating Cancer Stem Cell Markers in Breast Carcinomas: A Systematic Review Protocol, Systematic Reviews (2017)
7. Recent Advancements in Polyaniline-Based Biosensors for Diagnosis of Cancers: A Comprehensive Review, TrAC - Trends in Analytical Chemistry (2024)
8. Circulating Tumor Cells and Dnas in Prostate Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
9. Liquid Biopsy in Bladder Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
10. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
11. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
12. Tumor-Educated Platelets, Clinica Chimica Acta (2024)
13. Liquid Biopsy As a New Tool for Diagnosis, Monitoring, and Personalized Medicine in Urogenital Cancers, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
14. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review, Acta Medica Iranica (2017)
15. Emerging Role of Micrornas As Liquid Biopsy Biomarkers in Lung Cancer: A Review, Acta Medica Iranica (2021)
16. Plasma Mir-21, Mir-155, Mir-10B, and Let-7A As the Potential Biomarkers for the Monitoring of Breast Cancer Patients, Scientific Reports (2018)
17. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
18. Investigating Socioeconomic Inequality in the Incidence of Breast Cancer in Iran: Interprovincial Analysis and Comparison, Scientific Journal of Kurdistan University of Medical Sciences (2025)
19. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)
20. Evaluation of Cstb and Dmbt1 Expression in Saliva of Gastric Cancer Patients and Controls, BMC Cancer (2022)